Gastroenterology

Gastroenterology

Volume 150, Issue 7, June 2016, Pages 1558-1560.e5
Gastroenterology

Original Research
Brief Report
No Association Between CEL–HYB Hybrid Allele and Chronic Pancreatitis in Asian Populations

https://doi.org/10.1053/j.gastro.2016.02.071Get rights and content

A hybrid allele between the carboxyl ester lipase gene (CEL) and its pseudogene, CELP (called CEL–HYB), generated by nonallelic homologous recombination between CEL intron 10 and CELP intron 10′, was found to increase susceptibility to chronic pancreatitis in a case–control study of patients of European ancestry. We attempted to replicate this finding in 3 independent cohorts from China, Japan, and India, but failed to detect the CEL–HYB allele in any of these populations. The CEL–HYB allele might therefore be an ethnic-specific risk factor for chronic pancreatitis. An alternative hybrid allele (CEL–HYB2) was identified in all 3 Asian populations (1.7% combined carrier frequency), but was not associated with chronic pancreatitis.

References (15)

  • R. Karam

    Biochim Biophys Acta

    (2013)
  • D.C. Whitcomb

    Nat Genet

    (1996)
  • C. Le Maréchal et al.

    Nat Genet

    (2006)
  • H. Witt

    Nat Genet

    (2000)
  • H. Witt et al.

    Nat Genet

    (2006)
  • J. Rosendahl et al.

    Nat Genet

    (2008)
  • E. Masson

    Hum Genet

    (2008)
There are more references available in the full text version of this article.

Cited by (58)

  • The genetic risk factor CEL-HYB1 causes proteotoxicity and chronic pancreatitis in mice

    2022, Pancreatology
    Citation Excerpt :

    The allele has also been investigated in pancreatic cancer patients with negative results regarding disease association [18,19]. Notably, CEL-HYB1 was absent from three different Asian cohorts of CP patients [20]. Instead, an alternative hybrid allele (CEL-HYB2), with a premature stop codon in exon 10, was discovered.

View all citing articles on Scopus

Conflicts of interest The authors disclose no conflicts.

Funding Wen-Bin Zou is a joint PhD student between Changhai Hospital and INSERM U1078 and received a 1-year scholarship (2015) from the China Scholarship Council (No. 201403170271). Support for this study came from the National Natural Science Foundation of China (Grant Nos. 81470884, 81422010 [Z.L.]), the Shanghai Rising-Star Program (Grant No. 13QA1404600 [Z.L.]), the HIROMI Medical Research Foundation (A.M.), the Mother and Child Health Foundation (A.M.), the Smoking Research Foundation (A.M.), the Pancreas Research Foundation of Japan (E.N.), the Ministry of Health, Labour and Welfare of Japan (Principal investigators: Yoichi Matsubara and Yoshifumi Takeyama), Council of Scientific and Industrial Research, Ministry of Science and Technology, Government of India (GENESIS; Grant No. BSC0121 [G.R.C.]), the Conseil Régional de Bretagne, the Association des Pancréatites Chroniques Héréditaires, the Association de Transfusion Sanguine et de Biogénétique Gaetan Saleun, and the Institut National de la Santé et de la Recherche Médicale (INSERM), France.

Author names in bold designate shared co-first authorship.

Authors share co-first authorship.

§

Authors share co-senior authorship.

View full text